Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Palynziq- Pegvaliase-Pqpz Injection Solution 20Mg/Ml pfs 10X1ml

Item No.:RX895763 895763  NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345  UPC No.:3-68135-67345-3 368135-673453 368135-673453  MPN 567345Item No.:RX895763 895763  NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345  UPC No.:3-68135-67345-3 368135-673453 368135-673453  MPN 567345Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.Item No.:RX895763 895763  NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345  UPC No.:3-68135-67345-3 368135-673453 368135-673453  MPN 567345

Rx Item-Palynziq- Pegvaliase-Pqpz Injection Solution 20Mg/Ml pfs 10X1ml

$6378.00$6074.29

Item No.:RX895763 895763 NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345 UPC No.:3-68135-67345-3 368135-673453 368135-673453 MPN 567345 Item PALYNZIQ- pegvaliase-pqpz injection, solution 20MG/ml 10
Packager: BioMarin Pharmaceutical Inc.
Category: HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule: None
Marketing Status: Biologic Licensing Application
Only Lic.-Physician,Pharmacy,Denti

Have a question?

For: Phenylketonuria Palynziq (pegvaliase-pqpz) is a phenylalanine-metabolizing enzyme indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria. These highlights do not include all the information needed to use PALYNZIQ safely and effectively. See full prescribing information for PALYNZIQ. PALYNZIQ (pegvaliase-pqpz) injection, for subcutaneous use Initial U.S. Approval: 2018 WARNING: RISK OF ANAPHYLAXIS See full prescribing information for complete boxed warning. Anaphylaxis has been reported after administration of Palynziq and may occur at any time during treatment. (5.1) Administer the initial dose of Palynziq under the supervision of a healthcare provider equipped to manage anaphylaxis, and closely observe patients for at least 60 minutes following injection. Prior to self?injection, confirm patient competency with self?administration, and patient's and observer's (if applicable) ability to recognize signs and symptoms of anaphylaxis and to administer auto-injectable epinephrine, if needed. (2.4) Prescribe auto?injectable epinephrine. Prior to first dose, instruct the patient and observer (if applicable) on its appropriate use. Instruct the patient to seek immediate medical care upon its use. Instruct patients to carry auto-injectable epinephrine with them at all times during Palynziq treatment. (2.4, 5.1) Palynziq is available only through a restricted program called the Palynziq REMS. (5.2) INDICATIONS AND USAGE Palynziq is a phenylalanine-metabolizing enzyme indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management. (1) DOSAGE AND ADMINISTRATION Dosage (2.1) Obtain baseline blood phenylalanine concentration before initiating treatment. The recommended initial dosage is 2.5 mg subcutaneously once weekly for 4 weeks. Titrate the dosage in a step-wise manner over at least 5 weeks based on tolerability to achieve a dosage of 20 mg subcutaneously once daily. See full prescribing information for titration regimen. Assess patient tolerability, blood phenylalanine concentration, and dietary protein and phenylalanine intake throughout treatment. Consider increasing the dosage to a maximum of 40 mg subcutaneously once daily in patients who have been on 20 mg once daily continuously for at least 24 weeks and who have not achieved either a 20% reduction in blood phenylalanine concentration from pre-treatment baseline or a blood phenylalanine concentration less than or equal to 600 micromol/L. Discontinue Palynziq in patients who have not achieved at least a 20% reduction in blood phenylalanine concentration from pre-treatment baseline or a blood phenylalanine concentration less than or equal to 600 micromol/L after 16 weeks of continuous treatment with the maximum dosage of 40 mg once daily. Reduce the dosage and/or modify dietary protein and phenylalanine intake, as needed, to maintain blood phenylalanine concentrations within a clinically acceptable range and above 30 micromol/L. Blood Phenylalanine Monitoring and Diet (2.2) Obtain blood phenylalanine concentrations every 4 weeks until a maintenance dosage is established. After a maintenance dosage is established, periodically monitor blood phenylalanine concentrations. Counsel patients to monitor dietary protein and phenylalanine intake, and adjust as directed by their healthcare provider. Premedication (2.3, 5.1, 5.3) Consider premedication for hypersensitivity reactions. Administration Instructions (2.4) Rotate injection sites. If more than one injection is needed for a single dose, the injection sites should be at least 2 inches away from each other. DOSAGE FORMS AND STRENGTHS Injection: 2.5 mg/0.5 mL, 10 mg/0.5 mL, and 20 mg/mL in a single-dose prefilled syringe. (3) CONTRAINDICATIONS None. (4) WARNINGS AND PRECAUTIONS Hypersensitivity Reactions, Other than Anaphylaxis: Management should be based on the severity of the reaction, recurrence, and clinical judgement, and may include dosage adjustment, temporary drug interruption, or treatment with antihistamines, antipyretics, and/or corticosteroids. (5.3) ADVERSE REACTIONS Most common adverse reactions (at least 20% in either treatment phase) are: injection site reactions, arthralgia, hypersensitivity reactions, headache, generalized skin reactions lasting at least 14 days, pruritus, nausea, abdominal pain, oropharyngeal pain, vomiting, cough, diarrhea, and fatigue. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact BioMarin Pharmaceutical Inc. at 1-866-906-6100, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. DRUG INTERACTIONS Effect of Palynziq on Other PEGylated Products: Monitor for hypersensitivity reactions, including anaphylaxis, with concomitant treatment. (7.1) USE IN SPECIFIC POPULATIONS Pregnancy: May cause fetal harm. (8.1) See 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: 6/2018

Item No.:RX895763 895763  NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345  UPC No.:3-68135-67345-3 368135-673453 368135-673453  MPN 567345
Palynziq- Pegvaliase-Pqpz
Item No.:RX895763 895763 NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345 UPC No.:3-68135-67345-3 368135-673453 368135-673453 MPN 567345

Item No.:RX895763 895763  NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345  UPC No.:3-68135-67345-3 368135-673453 368135-673453  MPN 567345
Palynziq- Pegvaliase-Pqpz
Item No.:RX895763 895763 NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345 UPC No.:3-68135-67345-3 368135-673453 368135-673453 MPN 567345

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
American Pharma Wholesale
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Item No.:RX895763 895763  NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345  UPC No.:3-68135-67345-3 368135-673453 368135-673453  MPN 567345
Palynziq- Pegvaliase-Pqpz
Item No.:RX895763 895763 NDC No.68135-0673-45 68135-673-45 68135-67345 68135067345 UPC No.:3-68135-67345-3 368135-673453 368135-673453 MPN 567345